Dr. Milch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 Congress St
Quincy, MA 02169Phone+1 617-471-0033Fax+1 617-770-4354
Education & Training
- Tufts Medical CenterResidency, Internal Medicine, 1991 - 1994
- Stony Brook University Health Sciences Center School of MedicineClass of 1991
Certifications & Licensure
- MA State Medical License 1994 - 2025
Publications & Presentations
PubMed
- 49 citationsMirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.Geert D'Haens, Marla Dubinsky, Taku Kobayashi, Peter M Irving, Stefanie Howaldt
The New England Journal of Medicine. 2023-06-29 - 387 citationsUstekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.Bruce E Sands, William J Sandborn, Remo Panaccione, Christopher D O'Brien, Hongyan Zhang
The New England Journal of Medicine. 2019-09-26 - 3 citationsA Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical TrialsAsit Parikh, Kristin Stephens, Eugene O. Major, I. Fox, Catherine Milch
Drug Safety. 2018-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: